Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Usana Health Sciences Sees Q3 Adj EPS $(0.15) vs $0.47 Est; Sees Sales $214.000M vs $224.128M Est

Author: Benzinga Newsdesk | October 09, 2025 05:12pm
Usana Health Sciences (NYSE:USNA) is looking for Q3 Adj EPS of $(0.15) vs $0.47 analyst estimate. sees sales of $214.000 million vs $224.128 million analyst estimate.

Posted In: USNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist